Conference
Intermittent cyclical etidronate therapy for the prevention of rheumatoid arthritis induced bone loss following 18 months of fluoride therapy or placebo.
Authors
Ioannidis G; Adachi JD; Bensen WG; Bianchi F; Cividino A; Sebaldt RJ; Gordon M; Goldsmith C
Volume
12
Pagination
pp. S642-S642
Publisher
BLACKWELL SCIENCE INC
Publication Date
August 1, 1997
Conference proceedings
JOURNAL OF BONE AND MINERAL RESEARCH
ISSN
0884-0431